AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7528129 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and Atenolol
Number of subjects: 0
Study 7528129 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 0
Study 7528129 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 0
Study 2973571 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg fenoterol hydrobromide
Number of subjects: 14
Study 2973571 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg ipratropium bromide
Number of subjects: 14
Study 2973571 — intervention group
Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 14
Study 30100558 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (TAT) with cilostazol
Number of subjects: 183
Study 30100558 — intervention group
Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (DAT)
Number of subjects: 183
Study 27787471 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (20 min·d, twice a week, during 12 weeks)
Number of subjects: 59
Study 27787471 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training
Number of subjects: 59
Study 27787471 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 59
Study 23059702 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulated delivery arm system
Number of subjects: 30
Study 23059702 — intervention group
Group type: COMPARATOR
Intervention: Straight delivery arm system
Number of subjects: 30
Study 24267484 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 80
Study 24267484 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 80
Study 21411836 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus casei Shirota)
Number of subjects: 84
Study 21411836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 19420956 — intervention group
Group type: EXPERIMENTAL
Intervention: Arsenicum album
Number of subjects: 25
Study 19420956 — intervention group
Group type: EXPERIMENTAL
Intervention: Natrum muriaticum
Number of subjects: 25
Study 19420956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 17014273 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group intervention for coping with AIDS bereavement (12-week duration)
Number of subjects: 267
Study 17014273 — intervention group
Group type: COMPARATOR
Intervention: Individual therapy upon request
Number of subjects: 267
Study 17014273 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group intervention for coping with AIDS bereavement
Number of subjects: 267
Study 15244255 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP chemotherapy
Number of subjects: 220
Study 15244255 — intervention group
Group type: EXPERIMENTAL
Intervention: CNOP chemotherapy
Number of subjects: 220
Study 11052327 — intervention group
Group type: EXPERIMENTAL
Intervention: Late scan (3 hr)
Number of subjects: 80
Study 11052327 — intervention group
Group type: COMPARATOR
Intervention: Early scan (45 min)
Number of subjects: 80
Study 9387196 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone exposure (0.22 ppm for 4 hours with exercise)
Number of subjects: 90
Study 9387196 — intervention group
Group type: COMPARATOR
Intervention: Air exposure (same exposure protocol)
Number of subjects: 90
Study 7935030 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens, 0.625 mg daily
Number of subjects: 33
Study 7935030 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens with cyclic medrogestone, 5 mg daily during the last 12 days of each 28 days treatment cycle
Number of subjects: 33
Study 3154698 — intervention group
Group type: EXPERIMENTAL
Intervention: Molsidomine (4 mg)
Number of subjects: 32
Study 3154698 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (20 mg)
Number of subjects: 32
Study 30090923 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavier sedation (modified observer's assessment of sedation score of 0-2)
Number of subjects: 200
Study 30090923 — intervention group
Group type: COMPARATOR
Intervention: Lighter sedation (observer's assessment of sedation score of 3-5)
Number of subjects: 200
Study 28406752 — intervention group
Group type: EXPERIMENTAL
Intervention: PCECV-I (Indian batches)
Number of subjects: 340
Study 28406752 — intervention group
Group type: COMPARATOR
Intervention: PCECV-G (German batch)
Number of subjects: 340
Study 28406752 — intervention group
Group type: EXPERIMENTAL
Intervention: PCECV-I and PCECV-G (all groups)
Number of subjects: 340
Study 25684609 — intervention group
Group type: EXPERIMENTAL
Intervention: Winking emoticon present
Number of subjects: 0
Study 25684609 — intervention group
Group type: EXPERIMENTAL
Intervention: No emoticon present
Number of subjects: 0
Study 25684609 — intervention group
Group type: COMPARATOR
Intervention: Gender
Number of subjects: 0
Study 23254230 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion 150mg bid for 7 weeks
Number of subjects: 540
Study 23254230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study 23254230 — intervention group
Group type: COMPARATOR
Intervention: Bupropion vs. Placebo
Number of subjects: 540
Study 23254230 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater study session attendance
Number of subjects: 540
Study 23254230 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer years of smoking
Number of subjects: 540
Study 23254230 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline cotinine
Number of subjects: 540
Study 23254230 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 540
Study 23254230 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight efficacy
Number of subjects: 540
Study 20667666 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute cocaine use
Number of subjects: 160
Study 20667666 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute heavy alcohol use
Number of subjects: 160
Study 20667666 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 160
Study 18256071 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium 80 mug followed by Salbutamol 400 mug
Number of subjects: 5756
Study 18256071 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 5756
Study 16724575 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed bacterium combination of Lactobacillus gasseri and Bifidobacterium longum
Number of subjects: 169
Study 16724575 — intervention group
Group type: COMPARATOR
Intervention: Mono-bacterium Enterococcus faecium
Number of subjects: 169
Study 12195132 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 9193
Study 12195132 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 9193
Study 9706939 — intervention group
Group type: EXPERIMENTAL
Intervention: ETT cuff inflation in the pharynx
Number of subjects: 20
Study 9706939 — intervention group
Group type: COMPARATOR
Intervention: Fiberoptic bronchoscopy
Number of subjects: 20
Study 7891047 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablets containing 66 mg ferrous iron (as fumarate) daily
Number of subjects: 120
Study 7891047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 2204651 — intervention group
Group type: EXPERIMENTAL
Intervention: Golytely
Number of subjects: 124
Study 2204651 — intervention group
Group type: EXPERIMENTAL
Intervention: Enema preparation
Number of subjects: 124
Study 2204651 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 124
Study 656287 — intervention group
Group type: EXPERIMENTAL
Intervention: Large particle size digoxin
Number of subjects: 10
Study 656287 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 10
Study 656287 — intervention group
Group type: EXPERIMENTAL
Intervention: Propantheline
Number of subjects: 10
Study 656287 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard digoxin
Number of subjects: 10
Study 656287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7083601 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU) 160 mg daily by mouth
Number of subjects: 4
Study 7083601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 31200994 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving incision
Number of subjects: 516
Study 31200994 — intervention group
Group type: COMPARATOR
Intervention: Conventional incision
Number of subjects: 516
Study 29565951 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mL of 0.25% bupivacaine plus 1 µg/kg dexmedetomidine (GD group)
Number of subjects: 60
Study 29565951 — intervention group
Group type: COMPARATOR
Intervention: 30 mL of 0.25% bupivacaine only (GB group)
Number of subjects: 60
Study 27436880 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin treatment arm
Number of subjects: 4428
Study 27436880 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment arm
Number of subjects: 4428
Study 24798770 — intervention group
Group type: EXPERIMENTAL
Intervention: dolutegravir/abacavir/lamivudine FDC tablet
Number of subjects: 66
Study 24798770 — intervention group
Group type: EXPERIMENTAL
Intervention: dolutegravir/abacavir/lamivudine FDC tablet with a high-fat meal
Number of subjects: 66
Study 22776095 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate- to high-intensity Nordic Walking (NW) program (n = 26)
Number of subjects: 49
Study 22776095 — intervention group
Group type: COMPARATOR
Intervention: Supervised low-intensity walking (LIW) program (n = 23)
Number of subjects: 49
Study 22776095 — intervention group
Group type: EXPERIMENTAL
Intervention: Both NW and LIW groups
Number of subjects: 49
Study 20852413 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity cyclette exercise (≤70% maximum heart rate)
Number of subjects: 10
Study 20852413 — intervention group
Group type: COMPARATOR
Intervention: Seated rest (control condition)
Number of subjects: 10
Study 17687882 — intervention group
Group type: EXPERIMENTAL
Intervention: CRA Plus Vouchers
Number of subjects: 37
Study 17687882 — intervention group
Group type: COMPARATOR
Intervention: Standard Treatment
Number of subjects: 37
Study 15843697 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) via face mask with patient controlled analgesia (PCA)
Number of subjects: 52
Study 15843697 — intervention group
Group type: COMPARATOR
Intervention: Intermittent Positive Pressure Ventilation (IPPV) with endotracheal intubation (ETI)
Number of subjects: 52
Study 11887531 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) for Class I cavity preparations
Number of subjects: 60
Study 11887531 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) for Class II cavity preparations
Number of subjects: 60
Study 11887531 — intervention group
Group type: COMPARATOR
Intervention: Conventional cavity preparation for Class II cavity preparations
Number of subjects: 60
Study 11887531 — intervention group
Group type: COMPARATOR
Intervention: Conventional cavity preparation for Class I cavity preparations
Number of subjects: 60
Study 11887531 — intervention group
Group type: COMPARATOR
Intervention: Amalgam restorations in Class I conventional preparations
Number of subjects: 60
Study 9790334 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH (0.2 mg/kg/day subcutaneously)
Number of subjects: 263
Study 9790334 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 263
Study 9790334 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH (therapeutically)
Number of subjects: 263
Study 9790334 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH
Number of subjects: 263
Study 7631514 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Edmonston-Zagreb strain (10(5.6) TDIC50)
Number of subjects: 85
Study 7631514 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose Connaught strain (10(3) TCID50)
Number of subjects: 85
Study 7631514 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose Schwarz strain (10(4) TCID50)
Number of subjects: 85
Study 2560000 — intervention group
Group type: EXPERIMENTAL
Intervention: Small group education for general practitioners (8 meetings discussing chronic asthma management)
Number of subjects: 454
Study 2560000 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 454
Study 319717 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized delta9-tetrahydrocannabinol (5 to 20 mg)
Number of subjects: 16
Study 319717 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized delta9-tetrahydrocannabinol (5 mg)
Number of subjects: 16
Study 319717 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized delta9-tetrahydrocannabinol
Number of subjects: 16
Study 319717 — intervention group
Group type: COMPARATOR
Intervention: Smoked delta9-tetrahydrocannabinol
Number of subjects: 16
Study 31997228 — intervention group
Group type: EXPERIMENTAL
Intervention: Shear wave elastography (SWE) in infertile patients (Group A)
Number of subjects: 100
Study 31997228 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 100
Study 31997228 — intervention group
Group type: EXPERIMENTAL
Intervention: SWE values in group A
Number of subjects: 100
Study 30917445 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene Blue Perfusion Test (MBPT)
Number of subjects: 28
Study 30917445 — intervention group
Group type: COMPARATOR
Intervention: Air Test (AT)
Number of subjects: 28
Study 30917445 — intervention group
Group type: EXPERIMENTAL
Intervention: Both tests (MBPT and AT)
Number of subjects: 28
Study 28783465 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser before bleaching
Number of subjects: 50
Study 28783465 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser after bleaching
Number of subjects: 50
Study 28783465 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser before and after bleaching
Number of subjects: 50
Study 28783465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 28783465 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study 26243555 — intervention group
Group type: EXPERIMENTAL
Intervention: HeART of Stroke (HoS) plus usual care
Number of subjects: 64
Study 26243555 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 64
Study 23929644 — intervention group
Group type: EXPERIMENTAL
Intervention: LADS mouthrinse (1.4% potassium oxalate)
Number of subjects: 0
Study 23929644 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive control (Sensodyne Original desensitising toothpaste)
Number of subjects: 0
Study 23929644 — intervention group
Group type: COMPARATOR
Intervention: Negative control (Crest Cavity Protection Regular toothpaste)
Number of subjects: 0
Study 21853767 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory awareness lesson with the dominant hand
Number of subjects: 29
Study 21853767 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory awareness lesson with the nondominant hand
Number of subjects: 29
Study 21853767 — intervention group
Group type: COMPARATOR
Intervention: Sham control group
Number of subjects: 29
Study 19164402 — intervention group
Group type: EXPERIMENTAL
Intervention: Group exercise held twice weekly for five weeks
Number of subjects: 56
Study 19164402 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group) with no person specifically responsible for exercise training
Number of subjects: 56
Study 16467067 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised bronchodilator (ipratropium 0.5 mg + salbutamol 2.5 mg) with 50% O2
Number of subjects: 16
Study 16467067 — intervention group
Group type: EXPERIMENTAL
Intervention: O2 (50%) alone
Number of subjects: 16
Study 16467067 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised bronchodilator (ipratropium 0.5 mg + salbutamol 2.5 mg) alone
Number of subjects: 16
Study 16467067 — intervention group
Group type: COMPARATOR
Intervention: Placebo with room air (RA)
Number of subjects: 16
Study 15001900 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional atrial incision/cryoablation during lateral tunnel Fontan
Number of subjects: 42
Study 15001900 — intervention group
Group type: COMPARATOR
Intervention: Standard lateral tunnel Fontan (Control)
Number of subjects: 42
Study 12468808 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (titrated from 10 to 75 mg in extended-release form)
Number of subjects: 39
Study 12468808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 9814471 — intervention group
Group type: EXPERIMENTAL
Intervention: Men aged 21-30 years
Number of subjects: 253
Study 9814471 — intervention group
Group type: COMPARATOR
Intervention: Men aged 31-86 years
Number of subjects: 253
Study 9814471 — intervention group
Group type: EXPERIMENTAL
Intervention: Short term study (n=36)
Number of subjects: 253
Study 9814471 — intervention group
Group type: EXPERIMENTAL
Intervention: Long term study (n=35)
Number of subjects: 253
Study 7698617 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg t.i.d. for 2 weeks (group O)
Number of subjects: 31
Study 7698617 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg t.i.d. + Amoxicillin 500 mg q.i.d. for 2 weeks (group O + A)
Number of subjects: 31
Study 2121948 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation
Number of subjects: 42
Study 2121948 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 42
Study 23134 — intervention group
Group type: COMPARATOR
Intervention: Oral theophylline, placebo aerosol (TP)
Number of subjects: 8
Study 23134 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo, rimiterol aerosol (PR)
Number of subjects: 8
Study 23134 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral theophylline, rimiterol aerosol (TR)
Number of subjects: 8
Study 23134 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo, placebo aerosol (PP)
Number of subjects: 8
Study 30865175 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttrial visits after TAPIR trial (24 and 48 weeks later)
Number of subjects: 395
Study 30865175 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttrial adherence measured by tenofovir diphosphate levels
Number of subjects: 395
Study 30865175 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of adequate adherence posttrial
Number of subjects: 395
Study 30865175 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence after trial completion
Number of subjects: 395
Study 30186989 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with ceftizoxime powder and clotrimazole ointment
Number of subjects: 87
Study 30186989 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 87
Study 27579635 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide-formoterol
Number of subjects: 11693
Study 27579635 — intervention group
Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 11693
Study 24342715 — intervention group
Group type: EXPERIMENTAL
Intervention: Five ear acupuncture points (Shen‐men, Spleen, Stomach, Hunger, Endocrine)
Number of subjects: 91
Study 24342715 — intervention group
Group type: EXPERIMENTAL
Intervention: Hunger acupuncture point only
Number of subjects: 91
Study 24342715 — intervention group
Group type: COMPARATOR
Intervention: Sham control (five ear acupuncture points with needles removed immediately after insertion)
Number of subjects: 91
Study 21993938 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent-port (IP) SSA setup
Number of subjects: 27
Study 21993938 — intervention group
Group type: COMPARATOR
Intervention: AD-SSA setups
Number of subjects: 27
Study 19681572 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week restorative care educational program (30 minutes weekly)
Number of subjects: 523
Study 19681572 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week restorative care educational program
Number of subjects: 523
Study 19681572 — intervention group
Group type: COMPARATOR
Intervention: Control group (single 30-minute in-service on managing behavioral problems)
Number of subjects: 523
Study 17147835 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural/psycho-educational group training for 8 weeks
Number of subjects: 72
Study 17147835 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention (Control)
Number of subjects: 72
Study 15113639 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-sharing group
Number of subjects: 0
Study 15113639 — intervention group
Group type: COMPARATOR
Intervention: Non cost-sharing group
Number of subjects: 0
Study 15113639 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-sharing group (non-chronic diseases)
Number of subjects: 0
Study 15113639 — intervention group
Group type: COMPARATOR
Intervention: Non cost-sharing group (non-chronic diseases)
Number of subjects: 0
Study 15113639 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-sharing group (essential drugs)
Number of subjects: 0
Study 15113639 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-sharing group (non-essential drugs)
Number of subjects: 0
Study 15113639 — intervention group
Group type: COMPARATOR
Intervention: Non cost-sharing group (essential drugs)
Number of subjects: 0
Study 15113639 — intervention group
Group type: COMPARATOR
Intervention: Non cost-sharing group (non-essential drugs)
Number of subjects: 0
Study 15113639 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall impact of cost-sharing program
Number of subjects: 0
Study 15113639 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescriptions above the upper bound of the cost-sharing schedule
Number of subjects: 0
Study 11454438 — intervention group
Group type: EXPERIMENTAL
Intervention: 0-hour food deprivation
Number of subjects: 0
Study 11454438 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-hour food deprivation
Number of subjects: 0
Study 11454438 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour food deprivation
Number of subjects: 0
Study 11454438 — intervention group
Group type: EXPERIMENTAL
Intervention: Food-deprived participants
Number of subjects: 0
Study 11454438 — intervention group
Group type: EXPERIMENTAL
Intervention: Binge eater group
Number of subjects: 0
Study 11454438 — intervention group
Group type: COMPARATOR
Intervention: Restrained eaters
Number of subjects: 0
Study 11454438 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0